Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Mito-LND (Mito-Loidamine) is an orally active and mitochondria-targeted inhibitor of oxidative phosphorylation.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 135.00 | |
2 mg | In stock | $ 193.00 | |
5 mg | In stock | $ 289.00 | |
10 mg | In stock | $ 478.00 | |
25 mg | In stock | $ 789.00 | |
50 mg | In stock | $ 1,080.00 | |
100 mg | In stock | $ 1,480.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 423.00 |
Description | Mito-LND (Mito-Loidamine) is an orally active and mitochondria-targeted inhibitor of oxidative phosphorylation. |
In vitro | Mito-LND inhibits cell growth of H2030BrM3 and A549 cells with IC50 of 0.74 μM and 0.69?μM, respectively. Mito-LND inhibits mitochondrial complex I and II activities with IC50 of 1.2 μM and 2.4?μM, respectively in H2030BrM3 cells. Mito-LND potently induces mitochondrial ROS generation in H2030BrM3 lung cancer cells. Mito-LND decreases the levels of phosphorylated AKT. Mito-LND also decreases the phosphorylation of P70S6K and other energy-sensing proteins in both the parental and metastatic lung cancer cell lines, indicating that Mito-LND specifically downregulates mTOR signaling. |
In vivo | Mito-LNDtreatment markedly enhanced potency against both lung cancer progression and metastasis. Mito-LND also decreases the rate of growth of A549 tumor xenografts. Mito-LND treatment shows a marked decrease in lung cancer brain metastasis in NOD/SCID mice bearing H2030BrM3 cells. |
Synonyms | Mito-Loidamine |
Molecular Weight | 801.62 |
Formula | C43H45BrCl2N3OP |
CAS No. | 2361564-49-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45mg/ml(56.14mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Mito-LND 2361564-49-8 Apoptosis Autophagy Immunology/Inflammation Metabolism NF-Κb Mitochondrial Metabolism OXPHOS Reactive Oxygen Species Mito-Lonidamine mTOR Mito-Loidamine p70S6K oxidative MitoLND Inhibitor inhibit mitochondria Mito LND anti-invasive anti-cancer phosphorylation AKT inhibitor